NIRO or No-go? Positioning a Novel Systemic Treatment Option for Desmoid Tumours

[1] Kasper B(2020)Desmoid tumors: to treat or not to treat, that is the question Cancer 126 5213-5221

[2] Raut CP(2022)A prospective observational study of active surveillance in primary desmoid fibromatosis Clin Cancer Res. 28 4027-4032

[3] Gronchi A(1992)Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis Dis Colon Rectum. 35 29-33

[4] Colombo C(2012)Transition of treatment for patients with extra-abdominal desmoid tumors: Nagoya University modality Cancers (Basel). 4 88-99

[5] Fiore M(1984)Extra-abdominal desmoid tumors J Bone Jt Surg Am. 66 1369-1374

[6] Grignani G(2010)Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor) Cancer 116 2258-2265

[7] Tsukada K(2009)Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis Eur J Cancer. 45 2930-2934

[8] Church JM(2017)Long-term efficacy of methotrexate plusvinblastine/vinorelbine in a large series of patients affected by desmoid-type fibromatosis Cancer J. 23 86-91

[9] Jagelman DG(2007)Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial J Clin Oncol. 25 501-506

[10] Nishida Y(2006)Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor) J Clin Oncol. 24 1195-1203

[1] Kasper B(2020)Desmoid tumors: to treat or not to treat, that is the question Cancer 126 5213-5221

[2] Raut CP(2022)A prospective observational study of active surveillance in primary desmoid fibromatosis Clin Cancer Res. 28 4027-4032

[3] Gronchi A(1992)Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis Dis Colon Rectum. 35 29-33

[4] Colombo C(2012)Transition of treatment for patients with extra-abdominal desmoid tumors: Nagoya University modality Cancers (Basel). 4 88-99

[5] Fiore M(1984)Extra-abdominal desmoid tumors J Bone Jt Surg Am. 66 1369-1374

[6] Grignani G(2010)Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor) Cancer 116 2258-2265

[7] Tsukada K(2009)Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis Eur J Cancer. 45 2930-2934

[8] Church JM(2017)Long-term efficacy of methotrexate plusvinblastine/vinorelbine in a large series of patients affected by desmoid-type fibromatosis Cancer J. 23 86-91

[9] Jagelman DG(2007)Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial J Clin Oncol. 25 501-506

[10] Nishida Y(2006)Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor) J Clin Oncol. 24 1195-1203